Advanced Biomed Inc.
corporate_fare Company Profile
Advanced Biomed Inc. (NASDAQ:ADVB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for ADVB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for ADVB spans 8-K, 10-Q, 10-K, DEF 14A.
Recent high-impact activity:
- Advanced Biomed Raises $112,000 in Private Placement at $0.35 per Share
- Advanced Biomed Q1 Loss Widens to $989K; Cash Down to $214K After $613K Credit Charge
- Advanced Biomed 10-K Reveals Material Weaknesses, $2.9M Credit Loss Provision, and $14M Divestiture Gain
- $25M Equity Purchase Pact Terminated, Removing Potential Dilution Overhang
- Advanced Biomed Ends $25M Equity Line with Helena Global, Having Sold No Shares
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 11,238 shares in ADVB as of the October 30, 2026 settlement, a 15.3% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 33.0% of ADVB volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.